Be A Freedom Fighter · Bill Library

HR 10798 — Silicosis Prevention and Treatment Act

Freedom score: -2 (scale −10 to +10)

Sponsor: Rep. Correa, J. Luis [D-CA-46] · Latest action: Referred to the House Committee on Energy and Commerce. (2026-10-13)

Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index

Findings — 6 highlighted provisions

Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.

  1. Sec. 1 — supplies the short title only; it changes no private legal obligation See in text ↓
  2. Sec. 2(a) — directs the HHS Secretary, acting through the HRSA Administrator, to award competitive grants for treatment of people with silicosis irrespective of their ability to pay and for education of workers in industries with high silica exposure. The duty is a grant-program duty, not a command that every private clinic provide uncompensated care or a new silica-exposure workplace standard See in text ↓
  3. Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective See in text ↓
  4. Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers See in text ↓
  5. Sec. 2(d) — defines State to include DC, territories/possessions and Indian Tribes for this grant section See in text ↓
  6. Sec. 2(e) — authorizes $10 million for each fiscal year 2027–2031. Authorization is not itself an appropriation or proof that grants will be funded or awarded See in text ↓

Full text (introduced version)

17 of 17 text blocks highlighted. Source: GovInfo, fetched cached.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10798 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10798 To establish a grant program for funding silicosis treatment and education, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 13, 2026 Mr. Correa (for himself and Ms. Dexter) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To establish a grant program for funding silicosis treatment and education, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

Sec. 1 — supplies the short title only; it changes no private legal obligation

This Act may be cited as the ``Silicosis Prevention and Treatment Act''.

SEC. 2. SILICOSIS CLINICS PROGRAM.

Sec. 2(a) — directs the HHS Secretary, acting through the HRSA Administrator, to award competitive grants for treatment of people with silicosis irrespective of their ability to pay and for education of workers in industries with high silica exposure. The duty is a grant-program duty, not a command that every private clinic provide uncompensated care or a new silica-exposure workplace standard

(a) Establishment.--The Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, (in this section referred to as the ``Secretary''), shall award grants, on a competitive basis, to eligible entities to treat individuals with silicosis, regardless of their ability to pay, and provide education to workers in industries with high exposure to silica.

Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective

(b) Eligible Entities.--To be eligible for a grant under this section, an entity shall be--

Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective

(1) a federally qualified health center (as defined in section 1861(aa) of the Social Security Act (42 U.S.C. 1395x(aa)));

Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective

(2) a hospital;

Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective

(3) a State or local health department; or

Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective

(4) a nonprofit health care clinic or nonprofit health care provider.

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(c) Use of Funds.--A grant awarded under this section may be used for--

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(1) outreach and education to raise awareness of silicosis;

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(2) screening, diagnosis, and treatment of silicosis;

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(3) education programs for patients, family members, and workers in industries heavily impacted by silicosis;

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(4) benefits counseling related to silicosis (including with respect to State and Federal compensation programs);

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(5) patient care and coordination related to silicosis (including individual patient care plans and referrals, as needed);

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(6) pulmonary rehabilitation to improve breathing in relation to silicosis; or

Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers

(7) such other activities as the Secretary determines appropriate.

Sec. 2(d) — defines State to include DC, territories/possessions and Indian Tribes for this grant section

(d) State Defined.--In this section, the term ``State'' means each of the several States, the District of Columbia, a territory or possession of the United States, or an Indian Tribe.

Sec. 2(e) — authorizes $10 million for each fiscal year 2027–2031. Authorization is not itself an appropriation or proof that grants will be funded or awarded

(e) Authorization of Appropriations.--There is authorized to be appropriated to carry out this section $10,000,000 for each of fiscal years 2027 through 2031. <all>

Findings source: bill-scores-v2-batch42-findings-2026-11-15.md. Highlights come only from that file; no finding, score, or provision was invented for this page.

What you can do

Contact your U.S. Representative and Senators about this bill.

Find your Representative Contact your Senators

Spot an error on this page? Report it.